Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mg
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The objective is evaluate, in healthy volunteers, the bioavailability of two products
containing metformine 500 mg to determine if they are bioequivalent and identify the
occurrence of adverse events.